Back to top
more

Doximity (DOCS)

(Real Time Quote from BATS)

$57.95 USD

57.95
364,799

-0.35 (-0.60%)

Updated Aug 5, 2025 11:30 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (71 out of 246)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Doximity (DOCS) Stock Moves -0.16%: What You Should Know

by Zacks Equity Research

Doximity (DOCS) concluded the recent trading session at $55.48, signifying a -0.16% move from its prior day's close.

Zacks Equity Research

Compelling Reasons for Investors to Hold on to Centene Stock

by Zacks Equity Research

CNC remains well-poised for growth on the back of an expanding customer base, improved premiums, strategic acquisitions and commendable cash reserves.

Zacks Equity Research

The Zacks Analyst Blog Highlights Doximity, BrightSpring Health Services and Embecta

by Zacks Equity Research

Doximity, BrightSpring Health Services and Embecta are part of the Zacks top Analyst Blog.

Nalak Das headshot

5 Momentum Stocks to Buy for January After a Tepid December

by Nalak Das

Five stocks have strong momentum for January. These are: DOCS, LUV, ALK, DBX, PARRA.

Zacks Equity Research

Ensign Group Bolsters Healthcare Portfolio With Nine New Facilities

by Zacks Equity Research

ENSG acquires operations of nine skilled nursing facilities, marking its debut in Alabama and strengthening its Tennessee footprint, to enhance care and grow its Skilled Services segment.

Urmimala Biswas headshot

3 Medical Services Stocks to Buy to Counter Labor Shortage Woes

by Urmimala Biswas

The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. DOCS, BTSG and EMBC are set to gain the most. However, healthcare staffing shortage is leading to an increase in labor wages.

Zacks Equity Research

Doximity (DOCS) Stock Moves -0.13%: What You Should Know

by Zacks Equity Research

The latest trading day saw Doximity (DOCS) settling at $53.39, representing a -0.13% change from its previous close.

Zacks Equity Research

Here's Why Encompass Health is a Smart Addition to Your Portfolio

by Zacks Equity Research

EHC is well-poised for growth on the back of robust demand for effective inpatient rehabilitation services, frequent expansion initiatives and solid cash reserves.

Zacks Equity Research

Should Janus Henderson Small Cap Growth Alpha ETF (JSML) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for JSML

Debasmita Chatterjee headshot

4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow

by Debasmita Chatterjee

Medical stocks are expected to reap the benefits of affordable health insurance plans, rising surgeries and widespread adoption of telehealth services in the days ahead. However, inflation and supply-chain woes may act as spoilsport.

Zacks Equity Research

Is Janus Henderson Small Cap Growth Alpha ETF (JSML) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for JSML

Zacks Equity Research

Doximity (DOCS) Ascends But Remains Behind Market: Some Facts to Note

by Zacks Equity Research

Doximity (DOCS) closed the most recent trading day at $58.18, moving +0.61% from the previous trading session.

Zacks Equity Research

Ensign Expands Footprint With Buyout of Eight Healthcare Facilities

by Zacks Equity Research

ENSG agrees to buy eight healthcare facilities from Providence Home and Community Care, expanding its footprint.

Debanjana Dey headshot

4 MedTech Stocks That Gained More Than 100% in 2024 With Room to Run

by Debanjana Dey

Here are some strong MedTech stocks - DOCS, CLOV, CLPT and HIMS - that are expected to provide promising gains.

Zacks Equity Research

Is biote Corp. (BTMD) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how biote Corp. (BTMD) and Doximity (DOCS) have performed compared to their sector so far this year.

Zacks Equity Research

The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte

by Zacks Equity Research

McKesson, Doximity and Veracyte are included in this Analyst Blog.

Kaibalya Pravo Dey headshot

Prescription for Profits: 3 Must-Buy Healthcare Stocks Before 2025

by Kaibalya Pravo Dey

The healthcare sector is undergoing significant changes, with technology, innovation and a patient-centric approach as the cornerstones of its growth.

Zacks Equity Research

The Zacks Analyst Blog Highlights Garmin, Sprouts Farmers Market, Doximity, Peloton Interactive and Planet Fitness

by Zacks Equity Research

Garmin, Sprouts Farmers Market, Doximity, Peloton Interactive and Planet Fitness are included in this Analyst Blog.

Nalak Das headshot

Buy 5 High-Flying Health & Fitness Stocks of 2024 With More Upside

by Nalak Das

Five Health & Fitness stocks have strong growth potential for 2025. These are GRMN, SFM, DOCS, PLNT and PTON.

Zacks Equity Research

Are Options Traders Betting on a Big Move in Doximity (DOCS) Stock?

by Zacks Equity Research

Investors need to pay close attention to Doximity (DOCS) stock based on the movements in the options market lately.

Zacks Equity Research

Are Medical Stocks Lagging Doximity (DOCS) This Year?

by Zacks Equity Research

Here is how Doximity (DOCS) and AxoGen (AXGN) have performed compared to their sector so far this year.

Zacks Equity Research

Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity

by Zacks Equity Research

Amazon, Maplebear, Exelixis and Doximity have been highlighted in this Screen of The Week article.

Zacks Equity Research

Zacks.com featured highlights Doximity, Impinj and Innodata

by Zacks Equity Research

Doximity, Impinj and Innodata have been highlighted in this Screen of The Week article.

Supriyo Bose headshot

3 Momentum Anomaly Stocks to Buy as Election Rally Fizzles

by Supriyo Bose

DOCS, PI and INOD are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.

Sanghamitra Saha headshot

Looking for Earnings Beat? Buy These 4 Top-Ranked Stocks

by Sanghamitra Saha

Top-ranked stocks Amazon.com (AMZN), Maplebear Inc. (CART), Exelixis (EXEL) and Doximity (DOCS) are likely to beat on the bottom line in their upcoming releases.